Affiliation: | 1. Department of Medical Oncology and Targeted Therapeutics in Solid Tumors Group (IDIBAPS), Hospital Cl?nic de Barcelona, Barcelona, Spain;2. Melanoma Unit, Radiology Service, Hospital Cl?nic, IDIBAPS, University of Barcelona, Barcelona, Spain;3. Melanoma Unit, Department of Dermatology, Hospital Cl?nic de Barcelona, Barcelona, Spain;4. Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain;5. Melanoma Unit, Department of Dermatology, Hospital Cl?nic de Barcelona, IDIBAPS, Barcelona University, Barcelona, Spain;6. Melanoma Unit, Radiotherapy Oncology, Hospital Cl?nic, IDIBAPS, Barcelona University, Barcelona, Spain;7. Leiden University Medical Centre, Leiden, The Netherlands;8. Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK;9. Department of Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, UK;10. Laboratorio Internacional de Investigacion sobre el Genoma Humano, Universidad Nacional Autonoma de Mexico, Santiago de Queretaro, Mexico;11. Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain;12. Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UKThese authors contributed equally. |